Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients - Takeaways - MDSpire

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients

  • By

  • Caterina Gianni

  • Emanuela Scarpi

  • Eva Blondeaux

  • Michela Palleschi

  • Filippo Merloni

  • Lorenzo Gasperoni

  • Fabio Puglisi

  • Elena Collovà

  • Palma Pugliese

  • Francesco Cognetti

  • Irene Giannubilo

  • Tommaso Ruelle

  • Lucia Del Mastro

  • Claudia Bighin

  • Antonino Musolino

  • Ugo De Giorgi

  • July 15, 2026

Share

  • 1

    The study analyzed the prognostic value of inflammatory markers in 114 patients with metastatic triple-negative breast cancer (TNBC).

  • 2

    High inflammatory scores, particularly NLR, MLR, PLR, and SII, were significantly associated with lower progression-free survival (PFS) and overall survival (OS).

  • 3

    Median PFS was 8.6 months and median OS was 17.7 months for the overall patient population at a median follow-up of 28 months.

  • 4

    In multivariable analysis, the number of metastatic sites, NLR, SII, and MLR were significant predictors of overall survival.

  • 5

    The findings suggest that inflammatory ratios may serve as feasible prognostic biomarkers in metastatic TNBC, pending validation in larger studies.

Original Source(s)

Related Content